Cervical Dysplasia Market to Report a CAGR of 7.2% Between 2 017 to 2024
by pragya1 · September 26 cheap air max mens , 2018

The global market for cervical dysplasia features a highly consolidated competitive landscape, with the top three companies accounting for more than three-fourth of the overall market in 2017, observes a recent report by Transparency Market Research. These top vendors, namely Qiagen AG, Hologic Inc. cheap air max womens , and F. Hoffmann-La Roche Ltd, have strengthened their hold on the market owing to strategies such as collaboration with leading pharmaceutical and biotechnology companies and successful and focused R&D activities.

Detail Report:

Low product penetration clubbed with vast untapped growth prospects across developing economies is a key incremental opportunity for market players. Thus, companies could benefit from increased focus on strong promotional campaigns in developing economies where nearly 90% of cervical cancer deaths occur on an annual basis.

Transparency Market Research estimates that the聽global cervical dysplasia market聽will exhibit a healthy CAGR of 7.2% over the period between 2017 and 2024. If the prediction holds true, the market, which valued at US$394.0 mn in 2017 cheap nike air max shoes , is expected to rise to US$640.2 mn by 2024.

Demand across Developed Regions to Remain Pivotal to Generating Sustainable Profits

In terms of diagnosis, the global cervical dysplasia market is dominated by the diagnostic tests segment, which accounted for over 86.3% of the overall market in 2017. The rising awareness regarding cervical dysplasia and the vast rise in cervical cancer screening programs in developed countries are the key factors attributed to the high share of the segment in the global market.

Request Sample:

Geographically, the market earns a large share of its overall revenue from developed regions such as North America and Europe, which collectively accounted for over 80% of the overall market in 2017. The trend is expected to remain strong over the forecast period as well. Nevertheless cheap air max shoes , emerging economies across regions such as Asia Pacific and Latin America also present highly promising growth opportunities.

Government-funded Healthcare Screening Programs to Present Vast Growth Opportunities

Funds invested by governments towards several healthcare screening programs in a number of developed countries with the aim of preventing several high-incidence cancers are key to the overall development of the global cervical dysplasia market. Over the forecast period as well, the impact of this factor on the overall development of the market is expected to remain significantly high. The rising number of people to undergo cervical screening tests such as Pap smear, HPV, and colposcopy owing to such government initiatives is an excellent growth area for market players.

Rising Aversion to Pap Smear Tests to Have Negative Impact on Market Development

Pap smear tests currently hold a significant share in the overall market for cervical dysplasia diagnostic tests. The trend is primarily attributed to the immense success of widespread Pap smear screening programs undertaken in developed countries. In the past decade, however cheap nike air max , the number of Pap screening tests has drastically come down, chiefly owing to less than optimal Pap test characteristics, with about 25% to 40% false-negative rate despite the implementation of extensive quality assurance standards.

Request table of content:

This potential for missing out on critical cervical cancer symptoms with Pap screening alone has led to the development of enhanced cytology-based screening technologies and increased research activities aimed at understanding the etiologic role of human papillomavirus in causing cervical cancer. The resultant advancements in HPV screening technologies have made HPV testing one of the primary cervical cancer screening tools in the past years, allowing this segment to largely surpass the business of Pap smear screening tests. Although this factor presents an incremental growth opportunity for players in the HPV testing market, the aversion to the lucrative Pap smear screening test segment is expected to hamper the global cervical dysplasia market in the near future.

Key Segments of the Global Cervical Dysplasia Market

Global Cervical Dysplasia Market Revenue, by Diagnosis

Diagnosis Test

Pap Smear Test

HPV Test

Biopsy

Diagnostic Device

Colposcopy

Global Cervical Dysplasia Market Revenue, by End User

Hospitals

Diagnostic Centers

Private Gynecologists鈥?Offices

Research & Academic Institutes

Ambulatory Surgical C

JERUS. Cheap Air Max Cheap Air Max Cheap Nike Air Max Cheap Air Max Mens Cheap Asics Kids Shoes Asics White Shoes Clearance Cheap Asics Gel Lyte III Shoes Cheap Asics Tiger Shoes Cheap Asics Kids Shoes Online Cheap Mens Puma Suede